These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. New drug-eluting stents with biodegradable polymers. Van Der Giessen WJ; Van Beusekom HM Minerva Cardioangiol; 2011 Feb; 59(1):31-8. PubMed ID: 21285929 [TBL] [Abstract][Full Text] [Related]
14. Molecular imaging of drug-eluting coronary stents: method development, optimization and selected applications. Huang JT; Hannah-Qiuhua L; Szyszka R; Veselov V; Reed G; Wang X; Price S; Alquier L; Vas G J Mass Spectrom; 2012 Feb; 47(2):155-62. PubMed ID: 22359324 [TBL] [Abstract][Full Text] [Related]
15. Heparin-immobilized polymers as non-inflammatory and non-thrombogenic coating materials for arsenic trioxide eluting stents. Gong F; Cheng X; Wang S; Zhao Y; Gao Y; Cai H Acta Biomater; 2010 Feb; 6(2):534-46. PubMed ID: 19607942 [TBL] [Abstract][Full Text] [Related]
16. Drug-eluting stents and glycoprotein IIb/IIIa inhibitors: combination therapy for the future. Leon MB; Bakhai A; Am Heart J; 2003 Oct; 146(4 Suppl):S13-7. PubMed ID: 14564301 [TBL] [Abstract][Full Text] [Related]
17. Rapamycin analogs for stent-based local drug delivery. Everolimus- and tacrolimus-eluting stents. Grube E; Buellesfeld L Herz; 2004 Mar; 29(2):162-6. PubMed ID: 15054588 [TBL] [Abstract][Full Text] [Related]
18. Comprehensive meta-analysis on drug-eluting stents versus bare-metal stents during extended follow-up. Roukoz H; Bavry AA; Sarkees ML; Mood GR; Kumbhani DJ; Rabbat MG; Bhatt DL Am J Med; 2009 Jun; 122(6):581.e1-10. PubMed ID: 19486720 [TBL] [Abstract][Full Text] [Related]
19. Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial. Byrne RA; Kastrati A; Kufner S; Massberg S; Birkmeier KA; Laugwitz KL; Schulz S; Pache J; Fusaro M; Seyfarth M; Schömig A; Mehilli J; Eur Heart J; 2009 Oct; 30(20):2441-9. PubMed ID: 19720642 [TBL] [Abstract][Full Text] [Related]
20. A prospective multicenter parallel-controlled trial of TIVOLI biodegradable-polymer-based sirolimus-eluting stent compared to ENDEAVOR zotarolimus-eluting stent for the treatment of coronary artery disease: 8-month angiographic and 2-year clinical follow-up results. Xu B; Dou KF; Han YL; Lü SZ; Yang YJ; Huo Y; Wang LF; Chen YD; Wang HC; Li WM; Chen JY; Wang L; Wang Y; Ge JB; Li W; Gao RL Chin Med J (Engl); 2011 Mar; 124(6):811-6. PubMed ID: 21518585 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]